Craig B. Reeder, MD

Craig B. Reeder is a Hematologist/Internist at Mayo Clinic Phoenix, Arizona. He has special interest in stem cell transplantation, myeloma, amyloidosis, lymphoma and cutaneous lymphoma.

Dr. Craig B. Reeder completed his MD from Southern Illinois University, Springfield. He completed Residency in Internal Medicine and Fellowship in Hematology from Mayo Clinic Rochester. Currently, he is Chair at Hematology Disease Oriented Group, Division of Hematology/Oncology, Department of Internal Medicine and core faculty member at Fellowship Program, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic.

Representative Publications:

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statementexternal link, opens in a new tab

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statementexternal link, opens in a new tab

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialexternal link, opens in a new tab

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma external link, opens in a new tab

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenstrom macroglobulinemia external link, opens in a new tab